
Alicon Castalloy Q2FY27: consolidated margin compresses to 9.7% despite 52% revenue surge
Alicon Castalloy's consolidated revenue for Q2 FY27 came in at ₹649.84 Cr, up 51.8% YoY from ₹428.18 Cr and up 12.4% QoQ from ₹578.01 Cr. Consolidated PAT of ₹17.60 Cr grew a slower 26.7% YoY (₹13.89 Cr) and 53.8% QoQ off a low base (₹11.45 Cr) — the gap between revenue growth and profit growth on a YoY basis is the real story, not the QoQ jump, and it flags margin dilution rather than a clean scale-up. EPS came in at ₹10.78 against ₹8.50 a year ago. No street estimates for this specific quarter were found — Alicon carries thin analyst coverage (one tracked estimate per Trendlyne) and no Q2 FY27 preview turned up in search, so vsStreet is marked unknown rather than guessed. Consolidated EBITDA margin (operating profit before exceptional items, adjusted for finance cost, depreciation and other income) came in at roughly 9.7% this quarter versus ~12.8% a year ago, and on a half-year basis H1 FY27 margin of ~9.6% sits about 250 bps below H1 FY26's ~12.1%. That runs directly against management's own guidance from the August 2026 concall of "at least 1% EBITDA margin improvement" for FY27 — on the H1 evidence so far this is a clear miss, not on-track. Net profit margin similarly compressed YoY to 2.71% from 3.24%, even as it improved sequentially from 1.98% in Q1. The scale of the YoY revenue jump (+51.8%) far outstripping the 12-15% volume growth management had guided to suggests aluminium-price pass-through is doing much of the topline work, diluting margins rather than adding profit at the same rate. Standalone and consolidated tell different stories this quarter: standalone PAT of ₹20.73 Cr grew 97% YoY (from ₹10.52 Cr), more than triple the consolidated growth rate. The gap traces to the European step-down subsidiaries, Illichmann Castalloy GmbH (Germany) and Illichmann Castalloy s.r.o. (Czech Republic): consolidated PBT (₹23.87 Cr) came in below standalone PBT (₹27.00 Cr) this quarter, whereas a year ago consolidated PBT (₹19.02 Cr) was above standalone (₹14.53 Cr) — a roughly ₹7.6 Cr swing pointing to the overseas units flipping from a profit contributor to a loss-making drag. On the corporate-action side, the board approved these results alongside a 1,15,000-ESOP grant to the CEO on October 26, and the company separately responded to a BSE query on a director resignation in September; neither bears directly on the print. No standalone management press release was available to cross-check management's own framing of the quarter. With H1 FY27 capex of ~₹32 Cr consolidated tracking well behind the ₹150 Cr full-year guidance (and behind the Shikrapur-facility-specific ₹125 Cr plan aimed at an incremental ₹500 Cr revenue run-rate in 4-5 years), H2 will need a sharper capex ramp to stay on plan. The quarter leaves two threads open: whether EBITDA margin claws back toward the guided improvement in H2, and whether the European subsidiaries' swing to a loss is a one-quarter wobble or the start of a trend.
Key Highlights
- Consolidated revenue ₹649.84 Cr, +51.8% YoY (₹428.18 Cr) and +12.4% QoQ (₹578.01 Cr)
- Consolidated PAT ₹17.60 Cr, +26.7% YoY (₹13.89 Cr) — profit growth trails revenue growth, signalling margin dilution
- EBITDA margin ~9.7% vs ~12.8% YoY; H1 FY27 ~9.6% vs H1 FY26 ~12.1%, missing the guided 'at least 1% improvement' for FY27
- NPM compressed YoY to 2.71% from 3.24%, though up sequentially from 1.98% in Q1 FY27
- Standalone PAT ₹20.73 Cr up 97% YoY vs consolidated's 26.7%, as European step-down subsidiaries swung from profit to loss contribution
- Consolidated EPS ₹10.78 vs ₹8.50 a year ago
- H1 FY27 capex ~₹32 Cr consolidated, well below half of the ₹150 Cr full-year capex guidance
Price Impact
More from ALICON